Table 2 Demographic and clinical characteristics of study groups defined by WC

Age (years)

59.2 ± 12.4

65.1 ± 8.9*

62.0 ± 8.7

BMI (kg/m2)

24.9 ± 2.2

26.8 ± 4.1

33.1 ± 4.8*

Hypertension

10.9%

59.7%*

67.6%*

Smoker

8.7%

20.9%*

16.2%

Aspirin use

5.9%

49.3%*

41.9%*

Insulin use

0.0%

26.9%*

39.2%*

Metformin use

0.0%

74.6%*

74.3%*

ACEI/ARB use

16.7%

59.7%*

67.6%*

CC Blocker use

0.0%

35.8%*

36.8%*

Beta blocker use

15.2%

44.8%*

50%*

Statin use

13.8%

64.2%*

62.2%*

Fasting plasma glucose(mg/dl)

93.5 ± 9.9

148.3 ± 44.5*

166.0 ± 57.6*

HbA1C (%)

5.9 ± 0.4

7.5 ± 1.6*

8.2 ± 1.6*

Low density lipoprotein cholesterol (mg/dl)

119.8 ± 31.1

89.1 ± 27.6*

94.5 ± 31.4*

High density lipoprotein cholesterol (mg/dl)

53.6 ± 12.0

46.4 ± 11.1*

44.6 ± 12.4*

Triglycerides (mg/dl)

121.0 ± 59.9

156.5 ± 108.5*

156.6 ± 105.2*

C-reactive protein (mg/dl)

0.3 ± 0.3

0.5 ± 0.5

0.9 ± 1.5*

HOMA-IR

2.0 ± 1.1

6.03 ± 12.3*

10.8 ± 17.8*

Creatinine (mg/dl)

0.9 ± 0.2

1.0 ± 0.4

1.1 ±0.7*

Systolic blood pressure (mmHg)

119.2 ± 13.9

134.0 ± 18.6*

153.3 ± 20.6*

Diastolic blood pressure (mmHg)

67.2 ± 8.6

73.1 ± 9.7

78.4 ± 10.3*

AI (%)

29.2 ± 9.4

34.0 ± 8.9*

38.8 ± 10.4*

PWV(m/sec)

6.0 ± 0.9

6.9 ± 1.8*

7.9 ± 3.5*